etrolizumab (RG7413) - Roche
Etrolizumab: Data from P3 HICKORY trial (NCT02100696) for ulcerative colitis in 2020 (Roche) - Sep 17, 2019 - Pharma Day 2019: Data from P3 BERGAMOT trial (NCT02394028) for moderate-to-severe Crohn's disease in 2021 
P3 data
https://www.roche.com/investors/agenda/roche-pharma-day-2019.htm
 
Sep 17, 2019
 
 
502e3529-3692-4ab7-a9ab-b56511d34068.jpg